A Decade-old Change in the Screening Rate for Hepatocellular Carcinoma Among a Hepatitis B Virus-infected Population in Korea

被引:13
|
作者
Kim, Hee Yeon [1 ]
Kim, Chang Wook [1 ]
Choi, Jong Young [1 ]
Park, Chung-Hwa [1 ]
Lee, Chang Don [2 ]
Yim, Hyeon Woo [3 ]
机构
[1] Catholic Univ Korea, Coll Med, Div Hepatol, Dept Internal Med, Seoul 06591, South Korea
[2] Int St Marys Hosp, Div Hepatobiliary, Dept Internal Med, Inchon 22711, South Korea
[3] Catholic Univ Korea, Coll Med, Dept Prevent Med, Seoul 06591, South Korea
关键词
Carcinoma; Health Surveys; Hepatitis B; Hepatocellular; Surveillance; LIVER-CANCER; PROGRAM;
D O I
10.4103/0366-6999.172551
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Evaluating a change in the screening rate for hepatocellular carcinoma (HCC) is critical for understanding screening implementation, and whether targeted population groups are receiving proper screening. This study examined recent nationwide changes in HCC screening use among hepatitis B virus (HBV)-infected populations after the introduction of the Korean National Cancer Screening Program and predictors of screening adherence. Methods: We analyzed 165 and 276 participants >= 40 years of age who were hepatitis B surface antigen-positive from 2001 (14,936 participants) to 2010-2011 (9159 participants) Korea National Health and Nutrition Examination Surveys, respectively. Demographic data, socioeconomic factors, and HCC screening use were collected by means of self-reported questionnaires. Results: The rate of HCC screening within the previous 2 years increased significantly from 17.5% in 2001 to 40.3% in 2010-2011 (P < 0.0001). The rate of HCC screening use increased from 2001 to 2010-2011 in all study populations. Subjects who had a higher income status and were aware of their infection were more likely to have undergone recent HCC screening. Conclusions: This study showed a substantial increase in HCC screening in high-risk HBV-infected subjects from 2001 to 2010-2011. However, the HCC screening participation rate remained suboptimal despite the introduction of the nationwide screening program. Efforts should be made to identify high-risk individuals and increase attendance at HCC screening events among high-risk groups.
引用
收藏
页码:15 / 21
页数:7
相关论文
共 50 条
  • [21] Impact of HIV on the survival of hepatocellular carcinoma in hepatitis C virus-infected patients
    Merchante, Nicolas
    Rodriguez-Fernandez, Miguel
    Figueruela, Blanca
    Rodriguez-Arrondo, Francisco
    Revollo, Boris
    Ibarra, Sofia
    Tellez, Francisco
    Merino, Esperanza
    Montero-Alonso, Marta
    Galindo, Maria J.
    Rivero-Juarez, Antonio
    de Los Santos, Ignacio
    Delgado-Fernandez, Marcial
    Garcia-Deltoro, Miguel
    Vera-Mendez, Francisco J.
    Garcia, Maria A.
    Aguirrebengoa, Koldo
    Portu, Joseba
    Rios-Villegas, Maria J.
    Villalobos, Marina
    Aleman-Valls, Maria R.
    Minguez, Carlos
    Galera, Carlos
    Macias, Juan
    Pineda, Juan A.
    AIDS, 2020, 34 (10) : 1497 - 1507
  • [22] Dissecting epigenetic alterations between hepatitis B virus and hepatitis C virus-infected hepatocellular carcinoma using CpG island microarray
    Chen, C. M.
    Chen, W. E.
    Chen, C. Y.
    Wu, J. C.
    Chen, H. L.
    JOURNAL OF HEPATOLOGY, 2007, 46 : S127 - S127
  • [23] Hepatocellular Carcinoma Among the Golestan Cohort Study Participants Infected With Hepatitis B Virus: A Population-Based Study
    Poustchi, Hossein
    Moossavi, Shirin
    Abaei, Behrouz
    Khademi, Hooman
    Bagheri, Mohammad
    Malekzadeh, Reza
    GASTROENTEROLOGY, 2012, 142 (05) : S994 - S994
  • [24] Prevalence of Hepatitis Delta Virus Infection among Hepatitis B Virus-Infected and Exposed Patients
    Ramachandran, Krithiga
    Agarwal, Reshu
    Sharma, Manoj Kumar
    Bhatia, Vikram
    Gupta, Ekta
    JOURNAL OF GLOBAL INFECTIOUS DISEASES, 2020, 12 (04) : 197 - 201
  • [25] Prevalence of hepatitis D virus infection among hepatitis B virus-infected individuals in India
    Jat S.L.
    Gupta N.
    Kumar T.
    Mishra S.
    S A.
    Yadav V.
    Goel A.
    Aggarwal R.
    Indian Journal of Gastroenterology, 2015, 34 (2) : 164 - 168
  • [26] Survey of hepatitis B virus co-infection in hepatitis C virus-infected patients suffering from chronic hepatitis and hepatocellular carcinoma in Japan
    Koike, K
    Shimotouno, K
    Okada, S
    Okamoto, H
    Hayashi, N
    Ueda, K
    Kaneko, S
    Koike, K
    Yokosuka, O
    Chiba, T
    Marusawa, H
    Hino, O
    Utida, T
    Omata, M
    Juji, T
    Nojiri, N
    Takada, K
    Miyamura, T
    Osuga, T
    Ito, Y
    JAPANESE JOURNAL OF CANCER RESEARCH, 1999, 90 (11): : 1270 - 1272
  • [27] Preoperatively staging liver fibrosis using noninvasive method in Hepatitis B virus-infected hepatocellular carcinoma patients
    Gao, Hengyi
    Zhu, Feng
    Wang, Min
    Zhang, Hang
    Ye, Dawei
    Yang, Jiayin
    Jiang, Li
    Liu, Chang
    Qin, Renyi
    Yan, Lunan
    Xiao, Guangqin
    ONCOTARGET, 2017, 8 (03) : 4289 - 4300
  • [28] Hepatocellular carcinoma risk in chronic hepatitis B virus-infected compensated cirrhosis patients with low viral load
    Sinn, Dong Hyun
    Lee, Junggyu
    Goo, Juna
    Kim, Kyunga
    Gwak, Geum-Youn
    Paik, Yong-Han
    Choi, Moon Seok
    Lee, Joon Hyeok
    Koh, Kwang Cheol
    Yoo, Byung Chul
    Paik, Seung Woon
    HEPATOLOGY, 2015, 62 (03) : 694 - 701
  • [29] Plasma Adipokines and Risk of Hepatocellular Carcinoma in Chronic Hepatitis B Virus-Infected Carriers: A Prospective Study in Taiwan
    Chen, Chi-Ling
    Yang, Wei-Shiung
    Yang, Hwai-I
    Chen, Chuen-Fei
    You, San-Lin
    Wang, Li-Yu
    Lu, Sheng-Nan
    Liu, Chun-Jen
    Kao, Jia-Horng
    Chen, Pei-Jer
    Chen, Ding-Shinn
    Chen, Chien-Jen
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2014, 23 (08) : 1659 - 1671
  • [30] Direct-acting antivirals for hepatitis C virus-infected patients with hepatocellular carcinoma
    Tajiri, Kazuto
    Ito, Hiroyuki
    Kawai, Kengo
    Kashii, Yoshiro
    Hayashi, Yuka
    Murayama, Aiko
    Minemura, Masami
    Takahara, Terumi
    Shimizu, Yukihiro
    Yasuda, Ichiro
    WORLD JOURNAL OF HEPATOLOGY, 2022, 14 (06) : 1190 - 1199